ARG1 and COVID-19: These findings suggest that, while dexamethasone may at least partially explain the observed reduction in release of arginase-1 from neutrophils, it cannot explain the increased expression of arginase-1 by neutrophils from patients with severe COVID-19 and those in convalescence.